Vitamin D Deficiency and Placental Calcification in Low-risk Obstetric Population - Are They Related?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02190396|
Recruitment Status : Completed
First Posted : July 15, 2014
Last Update Posted : July 15, 2014
|Condition or disease|
|Vitamin D Deficiency|
Vitamin D deficiency is a public health problem prevalent throughout the World. Low blood 25-hydroxyvitamin D3 ( 25OHD ) level was found to be associated with preeclampsia, gestational diabetes, infectious diseases, decrease in fetal bone mineralization, and increase in fetal respiratory infections and infant wheezing .
Requirement of vitamin D is primarily met by the exposure of skin to sun and secondarily by intake of food. The provision of vitamin D from the skin depends upon melanin pigment, the use of sun screens, age, dressing style and seasonal changes . Placenta plays an important role in Vitamin D metabolism during pregnancy and some independent risk factors increasing the risk of placental dysfunction at fetomaternal interface also influence vitamin D metabolism [2,3]. Nevertheless, there can be a pathological change resulting from the effects of environmental factors on the placenta .
|Study Type :||Observational|
|Actual Enrollment :||60 participants|
|Official Title:||Vitamin D Deficiency and Placental Calcification in Low-risk Obstetric Population - Are They Related?|
|Study Start Date :||March 2014|
|Actual Primary Completion Date :||May 2014|
|Actual Study Completion Date :||May 2014|
Placental calcification of Grade 3
No placental calcification noted, the control group.
- Number of participants with low birth weight. [ Time Frame: Three months ]
- Percentage of delivery with cesarean section. [ Time Frame: Three months ]
Biospecimen Retention: None Retained
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02190396
|Zekai Tahir Burak Maternity Teaching Hospital|
|Principal Investigator:||Ali O Ersoy||Medical doctor|